effect of buprenorphine patch(when placed on the skin) after uterus removal for few hours
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: N711- Chronic inflammatory disease of uterusHealth Condition 2: C55- Malignant neoplasm of uterus, partunspecifiedHealth Condition 3: C55- Malignant neoplasm of uterus, partunspecified
- Registration Number
- CTRI/2020/10/028677
- Lead Sponsor
- IGMC Shimla
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
female patients who have to undergo elective transabdominal hysterectomy
Exclusion Criteria
patient refusal, patients with skin allergies,patient on opioid treatment,patient who are not fit for subarachanoid block
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method